Process development

Process development

featured image of Revolutionizing Vaccine Development: Faster and Cheaper with Modeling

Revolutionizing Vaccine Development: Faster and Cheaper with Modeling

BIOT

💉 Computer modeling techniques can revolutionize the vaccine sector, but harmonized guidelines are crucial for their success.

featured image of Cell and Gene Therapy: $82B Market by 2032 - Trends Challenges and Innovations

Cell and Gene Therapy: $82B Market by 2032 – Trends Challenges and Innovations

BIOT

📰 The global cell and gene therapy market is expected to reach $82.24 billion by 2032, with a current size of $15.54 billion in 2022. - Precedence Research 🧫 🔬 Gene therapy is seeing a rise in gene editing therapeutics, but cost and access remain challenges. 💉 📈 Autologous CAR-T cell therapies are moving to earlier treatment stages, while allogeneic cell therapies and solid tumor therapies are being developed. 🤖 💼 Collaboration and flexible regulatory pathways are key to advancing the industry and delivering therapies to patients. 💪

featured image of Uncovering the Perfect Price for CGT: A Global Quest

Uncovering the Perfect Price for CGT: A Global Quest

BIOT

🌍💰 Global collaboration is essential to strike a balance between affordable and sustainable price points in the CGT industry.

featured image of Supercharge Vaccine Development with Automation and Collaboration

Supercharge Vaccine Development with Automation and Collaboration

BIOT

🧪 Recombinant protein vaccines are safe, effective, and easy to store, making them a leading human vaccine technology. ⏰ Shortening the time from vaccine discovery to commercialization is crucial for better pandemic preparedness. 🤖 Automation and digitalization can speed up vaccine development. 👥 Collaboration and open access platforms can facilitate knowledge sharing and ensure global access to vaccines. 💪 Scalable biotech manufacturing facilities with modular and flexible technologies are essential for large-scale production. 🏭 CDMOs have become crucial in responding to vaccine production demands. 🌍 Ensuring stable supply chains and timely regulatory certifications is necessary for CDMOs.

featured image of Pharma's Tech Revolution: AI and Synbio Supercharge Biologics

Pharma’s Tech Revolution: AI and Synbio Supercharge Biologics

BIOT

📰 Pharma is using new technologies like AI and synthetic biology to maximize biologics manufacturing. 💊 Innovations are improving antibody stability and yield, accelerating production and drug development. 🌐

featured image of 2024: The Year of Breakthroughs in Bioprocessing?

2024: The Year of Breakthroughs in Bioprocessing?

BIOT

Will 2024 be the year of breakthroughs in bioprocessing? 🌟 Find out in this insightful article! Bioprocessing2024

featured image of Revolutionizing Biopharmaceutical Development: Mastering In-Process Monitoring

Revolutionizing Biopharmaceutical Development: Mastering In-Process Monitoring

BIOT

📰 Mastering In-Process Attribute Monitoring in Biopharmaceutical Development explores the importance of continuous monitoring and advanced technologies. 💡🧪📊🌐

featured image of The Future of Cell and Gene Therapy: Groundbreaking Advancements and Promising Potential

The Future of Cell and Gene Therapy: Groundbreaking Advancements and Promising Potential

BIOT

📰 Discover the future of cell and gene therapy in 2024! Learn about advancements, challenges, and its potential impact! 🧬🔬🌟

featured image of UK Accelerates Biologic Manufacturing with Next-Gen Therapies

UK Accelerates Biologic Manufacturing with Next-Gen Therapies

BIOT

📰 The U.K. is leading the way in biologic manufacturing, investing in cutting-edge therapies and advanced analytical technologies. 🇬🇧💉

featured image of Breakthrough Antibiotic Kills Superbug and Saves Lives

Breakthrough Antibiotic Kills Superbug and Saves Lives

BIOT

🔬 Roche presents resistance-breaking antibiotic! 🦠 Zosurabalpin kills carbapenem-resistant Acinetobacter baumannii by preventing lipopolysaccharide movement. 🧪🐭 MedicalAdvancements